Skip to main content
844-CARES-55 (844-227-3755) space Monday-Friday 8 AM-10 PM ET 844-227-3747

Insurance Navigation & Financial Help

We do not want concerns about cost or insurance coverage to come between you and your medication. Our Nurse Advocates are here to offer information about financial assistance options, as well as explain your insurance coverage, and help determine if OGSIVEO™ (nirogacestat) is covered.

CCP-DT-WHITE3
If you have commercial health insurance, you may pay as little as a $0 copay with the Commercial Copay Program.
There are no income requirements to participate in the program.*
CCP-MOB-WHITE3
If you have commercial health insurance, you may pay as little as a $0 copay with the Commercial Copay Program.
There are no income requirements to participate in the program.*
Patient Assistance Program (PAP)

Patient Assistance
Program (PAP)

If you are uninsured, lack coverage for OGSIVEO, or are experiencing financial hardship, the Patient Assistance Program may help you obtain OGSIVEO at no cost.*
Patient Assistance Program (PAP)

Patient Assistance
Program (PAP)

If you are uninsured, lack coverage for OGSIVEO, or are experiencing financial hardship, the Patient Assistance Program may help you obtain OGSIVEO at no cost.*
* Terms and conditions apply. Copay program is subject to an annual benefit maximum. PAP eligibility criteria and annual household income limits apply. Full terms and conditions provided during the enrollment process and are available upon request by contacting SpringWorks CareConnections at 844-CARES-55 (844-227-3755).

Independent Patient Assistance Foundations

Financial assistance may be available through independent foundations that are not controlled by or otherwise affiliated with SpringWorks Therapeutics. These foundations may be able to assist with copays, premiums, patient education, social services, etc.

SpringWorks Therapeutics does not influence or control the operations of independent patient assistance foundations and cannot guarantee assistance will be provided. Details and eligibility requirements can be found directly on the individual foundation websites.

Temporary Free Medication Programs for Eligible Patients
These programs may help you if you have commercial insurance and your insurance coverage is delayed, or you experience a gap in insurance coverage:

QUICK START PROGRAM

may help you start on OGSIVEO at no cost for a limited period of time if your insurance company is delayed in making a coverage decision.

Learn more

Quick Start Program

Eligible patients experiencing a qualified delay in their insurance coverage may receive a 30-day supply of OGSIVEO, and up to 1 additional refill, subject to program terms.

If you are waiting to see if your insurance will cover OGSIVEO, talk to your doctor, or call one of our Nurse Advocates to learn more about the Quick Start Program.

BRIDGE PROGRAM

may provide you with OGSIVEO at no cost for a limited period of time if you experience an interruption or gap in coverage.

Learn more

Bridge Program

Eligible patients experiencing a qualified lapse in their insurance coverage may receive a 30-day supply of OGSIVEO, and up to 2 additional refills, subject to program terms.

If you are currently on OGSIVEO and your insurance has changed, talk to your doctor, or call one of our Nurse Advocates to learn more about the Bridge Program.

Terms and conditions apply. Full terms and conditions provided during enrollment process and are available upon request by contacting SpringWorks CareConnections at 844-CARES-55 (844-227-3755).
SpringWorks CareConnections
Enrollment in SpringWorks
CareConnections is simple
Springworks Therapeutics

© SpringWorks Therapeutics, Inc. All rights reserved. C_OGS_US_0010 11/23

OGSIVEO and SpringWorks CareConnections are trademarks of SpringWorks Therapeutics, Inc. All other trademarks are the property of their respective owners.

OGSIVEO and SpringWorks CareConnections are trademarks of SpringWorks Therapeutics, Inc. All other trademarks are the property of their respective owners.

This site is intended for U.S. audiences only.